Your browser doesn't support javascript.
loading
Epithelial RNase H2 Maintains Genome Integrity and Prevents Intestinal Tumorigenesis in Mice.
Aden, Konrad; Bartsch, Kareen; Dahl, Joseph; Reijns, Martin A M; Esser, Daniela; Sheibani-Tezerji, Raheleh; Sinha, Anupam; Wottawa, Felix; Ito, Go; Mishra, Neha; Knittler, Katharina; Burkholder, Adam; Welz, Lina; van Es, Johan; Tran, Florian; Lipinski, Simone; Kakavand, Nassim; Boeger, Christine; Lucius, Ralph; von Schoenfels, Witigo; Schafmayer, Clemens; Lenk, Lennart; Chalaris, Athena; Clevers, Hans; Röcken, Christoph; Kaleta, Christoph; Rose-John, Stefan; Schreiber, Stefan; Kunkel, Thomas; Rabe, Björn; Rosenstiel, Philip.
Afiliação
  • Aden K; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany; First Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany. Electronic address: k.aden@ikmb.uni-kiel.de.
  • Bartsch K; Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
  • Dahl J; Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina.
  • Reijns MAM; MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Esser D; Institute for Experimental Medicine, Christian-Albrechts-University, Kiel, Germany.
  • Sheibani-Tezerji R; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Sinha A; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Wottawa F; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Ito G; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Mishra N; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Knittler K; Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
  • Burkholder A; Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina.
  • Welz L; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • van Es J; Hubrecht Institute/Royal Netherlands Academy of Arts and Sciences, Princess Maxima Centre and University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Tran F; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany; First Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Lipinski S; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Kakavand N; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Boeger C; Department of Pathology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Lucius R; Anatomical Institute, Christian-Albrechts-University, Kiel, Germany.
  • von Schoenfels W; Department of Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Schafmayer C; Department of Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Lenk L; Department of Pediatrics, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Chalaris A; Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
  • Clevers H; Hubrecht Institute/Royal Netherlands Academy of Arts and Sciences, Princess Maxima Centre and University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Röcken C; Department of Pathology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Kaleta C; Institute for Experimental Medicine, Christian-Albrechts-University, Kiel, Germany.
  • Rose-John S; Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
  • Schreiber S; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany; First Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Kunkel T; Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina.
  • Rabe B; Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
  • Rosenstiel P; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
Gastroenterology ; 156(1): 145-159.e19, 2019 01.
Article em En | MEDLINE | ID: mdl-30273559
BACKGROUND & AIMS: RNase H2 is a holoenzyme, composed of 3 subunits (ribonuclease H2 subunits A, B, and C), that cleaves RNA:DNA hybrids and removes mis-incorporated ribonucleotides from genomic DNA through ribonucleotide excision repair. Ribonucleotide incorporation by eukaryotic DNA polymerases occurs during every round of genome duplication and produces the most frequent type of naturally occurring DNA lesion. We investigated whether intestinal epithelial proliferation requires RNase H2 function and whether RNase H2 activity is disrupted during intestinal carcinogenesis. METHODS: We generated mice with epithelial-specific deletion of ribonuclease H2 subunit B (H2bΔIEC) and mice that also had deletion of tumor-suppressor protein p53 (H2b/p53ΔIEC); we compared phenotypes with those of littermate H2bfl/fl or H2b/p53fl/fl (control) mice at young and old ages. Intestinal tissues were collected and analyzed by histology. We isolated epithelial cells, generated intestinal organoids, and performed RNA sequence analyses. Mutation signatures of spontaneous tumors from H2b/p53ΔIEC mice were characterized by exome sequencing. We collected colorectal tumor specimens from 467 patients, measured levels of ribonuclease H2 subunit B, and associated these with patient survival times and transcriptome data. RESULTS: The H2bΔIEC mice had DNA damage to intestinal epithelial cells and proliferative exhaustion of the intestinal stem cell compartment compared with controls and H2b/p53ΔIEC mice. However, H2b/p53ΔIEC mice spontaneously developed small intestine and colon carcinomas. DNA from these tumors contained T>G base substitutions at GTG trinucleotides. Analyses of transcriptomes of human colorectal tumors associated lower levels of RNase H2 with shorter survival times. CONCLUSIONS: In analyses of mice with disruption of the ribonuclease H2 subunit B gene and colorectal tumors from patients, we provide evidence that RNase H2 functions as a colorectal tumor suppressor. H2b/p53ΔIEC mice can be used to study the roles of RNase H2 in tissue-specific carcinogenesis.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Ribonuclease H / Instabilidade Genômica / Células Epiteliais / Neoplasias Intestinais / Intestino Delgado Limite: Animals / Female / Humans / Male Idioma: En Revista: Gastroenterology Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Ribonuclease H / Instabilidade Genômica / Células Epiteliais / Neoplasias Intestinais / Intestino Delgado Limite: Animals / Female / Humans / Male Idioma: En Revista: Gastroenterology Ano de publicação: 2019 Tipo de documento: Article